Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.

Watanabe K, Miura I, Kanno-Nozaki K, Horikoshi S, Mashiko H, Niwa S, Yabe H.

Psychiatry Res. 2015 Dec 15;230(2):419-23. doi: 10.1016/j.psychres.2015.09.030.

PMID:
26416588
2.

Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background.

Brambilla F, Amianto F, Dalle Grave R, Fassino S.

BMC Psychiatry. 2014 Dec 24;14:376. doi: 10.1186/s12888-014-0376-7.

3.

Lower CSF MHPG predicts short-term risk for suicide attempt.

Galfalvy H, Currier D, Oquendo MA, Sullivan G, Huang YY, John Mann J.

Int J Neuropsychopharmacol. 2009 Nov;12(10):1327-35. doi: 10.1017/S1461145709990228.

4.

No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover.

Mann JJ, Currier D, Murphy L, Huang YY, Galfalvy H, Brent D, Greenhill L, Oquendo M.

J Affect Disord. 2008 Feb;106(1-2):117-21.

5.

Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.

Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR.

Biol Psychiatry. 2004 Apr 1;55(7):739-44.

PMID:
15039003
6.

Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys.

Clarke AS, Ebert MH, Schmidt DE, McKinney WT, Kraemer GW.

Biol Psychiatry. 1999 Jul 15;46(2):221-8.

PMID:
10418697
7.

Family psychiatric history, cerebrospinal fluid monoamine metabolites, and temperament in infants.

Constantino JN, Murphy DL, Morris JA.

Biol Psychiatry. 1999 Mar 1;45(5):626-32.

PMID:
10088050
8.

Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.

Hatzimanolis J, Lykouras L, Markianos M, Oulis P.

Prog Neuropsychopharmacol Biol Psychiatry. 1998 Oct;22(7):1077-85.

PMID:
9829289
9.

Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.

Fleischhaker C, Schulz E, Remschmidt H.

J Psychiatr Res. 1998 Sep-Oct;32(5):325-33.

PMID:
9789212
10.

Predicting haloperidol treatment response in chronic schizophrenia.

van Kammen DP, Kelley ME, Yao JK, Gilbertson MW, Gurklis JA, Inosaka T, Saito H, Peters JL, Sato M.

Psychiatry Res. 1996 Aug 30;64(1):47-58.

PMID:
8888364
11.
12.

Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.

Chang WH, Chen TY, Lin SK, Lung FW, Lin WL, Hu WH, Yeh EK.

Biol Psychiatry. 1990 Mar 1;27(5):510-8.

PMID:
2310806
13.
14.

Clonidine in the treatment of mixed bipolar disorder.

Kontaxakis V, Markianos M, Markidis M, Stefanis C.

Acta Psychiatr Scand. 1989 Jan;79(1):108-10.

PMID:
2467523
15.

Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.

Kirch DG, Jaskiw G, Linnoila M, Weinberger DR, Wyatt RJ.

Psychiatry Res. 1988 Sep;25(3):233-42.

PMID:
2903509
16.

Psychopathology in substance abusers: diagnosis and treatment.

Mirin SM, Weiss RD, Michael J, Griffin ML.

Am J Drug Alcohol Abuse. 1988;14(2):139-57. Review. No abstract available.

PMID:
3052036
17.

Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.

Giedke H, Gaertner H, Breyer-Pfaff U, Rein W, Axmann D.

Eur Arch Psychiatry Neurol Sci. 1986;235(6):329-38.

PMID:
3527706
18.

Urinary 3-methoxy-4-hydroxyphenylglycol in affective and schizophrenic patients. Behavior and symptom correlates.

Mueser KT, Rosen AJ, Javaid JI, Davis JM.

Neuropsychobiology. 1986;15(2):57-61.

PMID:
3093916
19.

Human aggression and the role of central serotonin.

Mühlbauer HD.

Pharmacopsychiatry. 1985 Mar;18(2):218-21.

PMID:
2410938
20.

Catecholamine metabolism during clonidine withdrawal.

Martin PR, Ebert MH, Gordon EK, Weingartner H, Kopin IJ.

Psychopharmacology (Berl). 1984;84(1):58-63.

PMID:
6436892
Items per page

Supplemental Content

Loading ...
Support Center